Order Article Reprints

Yi YW, You KS, Han S, Ha IJ, Park J-S, Lee S-G, Seong Y-S. Inhibition of IκB Kinase Is a Potential Therapeutic Strategy to Circumvent Resistance to Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer Cells. Cancers. 2022; 14(21):5215. https://doi.org/10.3390/cancers14215215

Yi, Yong Weon, Kyu Sic You, Sanghee Han, In Jin Ha, Jeong-Soo Park, Seok-Geun Lee, and Yeon-Sun Seong. 2022. "Inhibition of IκB Kinase Is a Potential Therapeutic Strategy to Circumvent Resistance to Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer Cells" Cancers 14, no. 21: 5215. https://doi.org/10.3390/cancers14215215

Yi, Y. W., You, K. S., Han, S., Ha, I. J., Park, J.-S., Lee, S.-G., & Seong, Y.-S. (2022). Inhibition of IκB Kinase Is a Potential Therapeutic Strategy to Circumvent Resistance to Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer Cells. Cancers, 14(21), 5215. https://doi.org/10.3390/cancers14215215